11-126205603-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032795.3(RPUSD4):āc.661T>Cā(p.Ser221Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,614,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032795.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPUSD4 | NM_032795.3 | c.661T>C | p.Ser221Pro | missense_variant | 5/7 | ENST00000298317.9 | NP_116184.2 | |
RPUSD4 | NM_001363516.2 | c.661T>C | p.Ser221Pro | missense_variant | 5/7 | NP_001350445.1 | ||
RPUSD4 | XM_011543039.3 | c.82T>C | p.Ser28Pro | missense_variant | 3/5 | XP_011541341.1 | ||
RPUSD4 | NM_001144827.2 | c.632-64T>C | intron_variant | NP_001138299.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPUSD4 | ENST00000298317.9 | c.661T>C | p.Ser221Pro | missense_variant | 5/7 | 1 | NM_032795.3 | ENSP00000298317.4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251420Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135884
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727244
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.661T>C (p.S221P) alteration is located in exon 5 (coding exon 5) of the RPUSD4 gene. This alteration results from a T to C substitution at nucleotide position 661, causing the serine (S) at amino acid position 221 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at